These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34752901)

  • 1. Effective definition of low humoral response to Clostridioides difficile infection.
    Ramos-Martínez A; Serrano-Martínez F; Pintos I; Valencia-Alijo Á; Gutiérrez-Rojas Á; Cítores MJ; Ortiz-Balbuena J; Royuela A; Martínez-Ruiz R; Sánchez-Romero I; Asensio Á; Múñez E; Plaza A
    Anaerobe; 2021 Dec; 72():102475. PubMed ID: 34752901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of existing total anti-toxin B IgG immunity in outcomes of recurrent Clostridioides difficile infection.
    Rigo I; Young MK; Abhyankar MM; Xu F; Ramakrishnan G; Naz F; Madden GR; Petri WA
    Anaerobe; 2024 Jun; 87():102842. PubMed ID: 38552897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-toxin antibody is not associated with recurrent Clostridium difficile infection.
    Gilbert J; Leslie J; Putler R; Weiner S; Standke A; Penkevich A; Keidan M; Young VB; Rao K
    Anaerobe; 2021 Feb; 67():102299. PubMed ID: 33227427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG antibody response to toxins A and B in patients with Clostridium difficile infection.
    Wullt M; Norén T; Ljungh A; Åkerlund T
    Clin Vaccine Immunol; 2012 Sep; 19(9):1552-4. PubMed ID: 22787196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating antibody and memory B-Cell responses to C. difficile toxins A and B in patients with C. difficile-associated diarrhoea, inflammatory bowel disease and cystic fibrosis.
    Monaghan TM; Robins A; Knox A; Sewell HF; Mahida YR
    PLoS One; 2013; 8(9):e74452. PubMed ID: 24058568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridioides difficile Infection Induces an Inferior IgG Response to That Induced by Immunization and Is Associated with a Lack of T Follicular Helper Cell and Memory B Cell Expansion.
    Amadou Amani S; Shadid T; Ballard JD; Lang ML
    Infect Immun; 2020 Feb; 88(3):. PubMed ID: 31871095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a new serological assay for the diagnosis of Clostridium difficile infections with prognostic value.
    von Bechtolsheim F; Varga A; Szereday L; Polgar B; Balassa T; Kocsis B; Peterfi Z; Miko E
    J Microbiol Methods; 2019 Dec; 167():105777. PubMed ID: 31733265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immune response as predictor of recurrence in Clostridium difficile infection.
    Bauer MP; Nibbering PH; Poxton IR; Kuijper EJ; van Dissel JT
    Clin Microbiol Infect; 2014 Dec; 20(12):1323-8. PubMed ID: 25041274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent Clostridioides difficile Infection Is Associated With Impaired T Helper Type 17 Immunity to C difficile Toxin B.
    Cook L; Rees WD; Wong MQ; Kwok WW; Levings MK; Steiner TS
    Gastroenterology; 2021 Mar; 160(4):1410-1413.e4. PubMed ID: 33253683
    [No Abstract]   [Full Text] [Related]  

  • 10. Protection from Clostridium difficile infection in CD4 T Cell- and polymeric immunoglobulin receptor-deficient mice.
    Johnston PF; Gerding DN; Knight KL
    Infect Immun; 2014 Feb; 82(2):522-31. PubMed ID: 24478068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel immunoassay for diagnosis of ongoing Clostridioides difficile infections using serum and medium enriched for newly synthesized antibodies (MENSA).
    Haddad NS; Nozick S; Kim G; Ohanian S; Kraft C; Rebolledo PA; Wang Y; Wu H; Bressler A; Le SNT; Kuruvilla M; Cannon LE; Lee FE; Daiss JL
    J Immunol Methods; 2021 May; 492():112932. PubMed ID: 33221459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection.
    Sun X; Hirota SA
    Mol Immunol; 2015 Feb; 63(2):193-202. PubMed ID: 25242213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Newly Secreted Antibodies Predicts Nonrecurrence in Primary Clostridioides difficile Infection.
    Haddad NS; Nozick S; Kim G; Ohanian S; Kraft CS; Rebolledo PA; Wang Y; Wu H; Bressler A; Le SNT; Kuruvilla M; Runnstrom MC; Ramonell RP; Cannon LE; Lee FE; Daiss JL
    J Clin Microbiol; 2022 Mar; 60(3):e0220121. PubMed ID: 35107301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters.
    Anosova NG; Brown AM; Li L; Liu N; Cole LE; Zhang J; Mehta H; Kleanthous H
    J Med Microbiol; 2013 Sep; 62(Pt 9):1394-1404. PubMed ID: 23518659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of the adaptive immune response to SlpA in Clostridium difficile infection.
    Mizrahi A; Bruxelle JF; Péchiné S; Le Monnier A
    Anaerobe; 2018 Dec; 54():164-168. PubMed ID: 30290246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridioides difficile toxin B subverts germinal center and antibody recall responses by stimulating a drug-treatable CXCR4-dependent mechanism.
    Norman KM; Lang GA; Shadid TM; Honold ST; Reel JM; Cox MA; Ballard JD; Lang ML
    Cell Rep; 2024 May; 43(5):114245. PubMed ID: 38761377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZupT Facilitates Clostridioides difficile Resistance to Host-Mediated Nutritional Immunity.
    Zackular JP; Knippel RJ; Lopez CA; Beavers WN; Maxwell CN; Chazin WJ; Skaar EP
    mSphere; 2020 Mar; 5(2):. PubMed ID: 32161145
    [No Abstract]   [Full Text] [Related]  

  • 18. Older Is Not Wiser, Immunologically Speaking: Effect of Aging on Host Response to Clostridium difficile Infections.
    Shin JH; High KP; Warren CA
    J Gerontol A Biol Sci Med Sci; 2016 Jul; 71(7):916-22. PubMed ID: 26809495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies specific for Clostridium difficile toxin B and their use in immunoassays.
    Müller F; Stiegler C; Hadding U
    J Clin Microbiol; 1992 Jun; 30(6):1544-50. PubMed ID: 1378062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal Antibodies to the C Terminus of Toxin A Prevent Colonization of Clostridium difficile.
    Hong HA; Hitri K; Hosseini S; Kotowicz N; Bryan D; Mawas F; Wilkinson AJ; van Broekhoven A; Kearsey J; Cutting SM
    Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28167669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.